Skip to main content
SpringerLink
Log in

Cases of SJS/TEN reported in rituximab recipients

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Conway Z. Direct Healthcare Professional Communication on the association of MabThera (rituximab) with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome. Internet Document : [3 pages], 20 May 2013. Available from: URL: http://www.mhra.gov.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cases of SJS/TEN reported in rituximab recipients. Reactions Weekly 1453, 4 (2013). https://doi.org/10.1007/s40278-013-3237-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-3237-0

Search

Navigation